SCHEMBL2468084

SCHEMBL2468084

CCN(CC)CCCN(C(=O)O)c1cccc(Cn2nc(-c3cc(F)cc(F)c3)ccc2=O)c1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 16/20 0.54
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CHRNE Q04844 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2464380 0.91 MET (0.63) MET
SCHEMBL2468334 0.89 MET (0.63) MET
SCHEMBL1951449 0.88 MET (0.54) MET
SCHEMBL2467505 0.88 MET (0.56) METMEN1KMT2A
SCHEMBL2491089 0.88 MET (0.59) MET
SCHEMBL2673295 0.87 MET (0.60) METMEN1KMT2A
SCHEMBL2497392 0.87 MET (0.56) METMEN1KMT2A
SCHEMBL2466696 0.87 MET (0.55) MET
SCHEMBL2492364 0.86 MET (0.60) MET
SCHEMBL2468835 0.86 MET (0.58) METMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 EP claimed